VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Amantadine+ Pregabalin
Preclinical
Small molecule
C
Cairo University
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Post-Thoracotomy Pain
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Post-Thoracotomy Pain
Preclinical
Completed
Clinical
Trials by Indication
[1]
Post-thoracotomy Pain
1 trial
Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome
Completed
·
—
·
N/A
·
NCT06833203
·
60 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Amantadine+ Pregabalin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Amantadine+ Pregabalin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Amantadine+ Pregabalin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Cairo University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
C
Cairo University
Related News